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Introduction
Tuberculosis (TB) disease, which kills 1.5 million people annu-
ally, is driven by poverty1. Having TB disease can also worsen 
impoverishment through loss of income and costs of access-
ing care2–5. Such costs can become “catastrophic”, leading 
patients to abandon treatment, develop drug-resistance, and die6. 
WHO’s 2015 End TB Strategy advocates elimination of cata-
strophic costs and provision of socioeconomic support for 
TB-affected households5. Nevertheless, there is minimal evi-
dence concerning the ideal interventions to realise this policy 
change6–10. This research will generate preliminary evidence to 
fill this knowledge gap in a low-income country: Nepal. The find-
ings will inform a randomised controlled trial of socioeconomic 
support for TB-affected households in Nepal.
Research from Peru has demonstrated that the severe socio-
economic impact of TB can lead to catastrophic costs (defined 
by WHO as >20% of a household’s annual income)6. The 
same team also demonstrated that socioeconomic interven-
tions for TB-affected households can mitigate catastrophic costs 
(Figure 1a), improve TB preventive therapy uptake (Figure 1b), 
and increase TB treatment success (Figure 1c)11–15.
However, despite these encouraging findings, Peru is a 
middle-income country with a strong TB program and exist-
ing national cash-transfer schemes. To make this research 
replicable and applicable in diverse settings, interventions simi-
lar to those in Peru need to be adapted to other country contexts, 
especially low-income countries (LICs) with less developed 
social protection schemes and high TB burden. One such country 
is Nepal.
The estimated incidence of TB in Nepal is 154/100,000 peo-
ple with 45,000 cases of TB being notified. Amongst these 
cases, there were 6,800 TB-related deaths. Multi-drug resistance 
(MDR) rates were 2.2% in new cases and 15% among retreatment 
      Amendments from Version 1
In response to the reviewers’ constructive comments, we have 
updated the following:
1. Provided more detail concerning coding methods for Project 2
2. Provided clarification concerning the selection and recruitment
of controls, including limitations and weaknesses in this method
3. Included a conceptual framework that informed the study
design and analysis (new Figure 3)
4. Included a logic model on the development of the
socioeconomic intervention, in line with MRC methods (new
Figure 4)
5. Clarified on data collection relating to social protection
These comments have been helpful in improving the protocol and 
we are grateful to the reviewers for their time and expertise.
Any further responses from the reviewers can be found at the 
end of the article
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cases. Importantly, despite good treatment success rates 
overall of more than 90% reported in Nepal, there remain short-
comings in TB care: treatment success rates were 70% for 
patients with MDR-TB and only 9% for those with HIV-TB 
co-infection; and accessibility of TB care remains low with 
treatment coverage of 70%16.
The poor treatment coverage in Nepal may, in part, be due to 
the financial impact on TB-affected households, which is esti-
mated to be high17. Responding to this estimated burden, the 
Nepal National TB Programme (NTP) national strategic plan for 
2016–2021 identifies provision of a support package to TB-
affected households (specifically targeting MDR-TB-affected 
households) as a priority aim for the country with the goal of 
reducing catastrophic costs. There is currently limited evidence 
concerning the potential acceptability, impact, or cost- 
effectiveness of such a package, with which to inform and guide 
this policy decision. A cohort study has suggested that, dur-
ing their illness, TB patients in Nepal experience decreased 
income and the total costs of accessing free TB treatment 
equate to nearly one quarter of annual household income17. 
Further studies in Nepal have shown that clinic fees make 
up the largest proportion of direct costs and that TB patients 
who are poorer, are migrants, or are from rural areas, experi-
ence a disproportionate burden of total costs18–20. It is vital that 
vulnerable TB patient households most at risk of incurring 
TB-related costs are identified in order to prevent and cure TB 
and mitigate further impoverishment and its consequences. 
In non-randomized studies, incurring higher TB-related 
costs and not receiving education about TB have both been 
found to be associated with worse TB treatment adherence and 
adverse TB treatment outcomes18,21. Therefore, the financial 
impact of having TB disease in Nepal constitutes a challenge to 
achieving TB control and elimination.
To date, no study of TB-affected households’ costs in Nepal 
has been performed using the standardised global methodol-
ogy for measuring costs related to accessing and engaging with 
TB care: the WHO TB Patient Costs Survey22,23. The studies 
above collected data at only one time point rather than repeated 
time points (e.g. cross-sectional rather than longitudinal) 
and did not robustly analyse the socioeconomic posi-
tion, nutritional status, coping strategies, or linkage to social 
protection of TB-affected households. There have been no 
trials of socioeconomic support for TB-affected households in 
Nepal but formative qualitative analysis and a non-randomized 
pilot interventional study (offering education and financial 
support to patients with MDR-TB) suggested improved treatment 
outcomes24.
However, studies reporting quantitative data alone will be insuf-
ficient to influence and change policy. Interaction with and 
among stakeholders has been described as the key facilita-
tor for knowledge translation and evidence-informed health 
policymaking25. These interactions can include policy dia-
logues between stakeholders to deliberate on a priority topic. 
Therefore, complementary to quantitative data, the focus group 
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Figure 1.  a) Catastrophic costs incurred by intervention (n=135) and control (n=147) TB-affected households of Callao, Peru. b) Preventive 
therapy initiation in household contacts of intervention (n=206) and control (n=204) TB-affected households of Callao, Peru. c) TB treatment 
success in patients from intervention (n=135) and control (n=147) TB-affected households of Callao, Peru. Part a) has been reproduced with 
permission from Wingfield et al.13 Parts b) and c) have been reproduced with permission from Wingfield et al.15.
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discussions (FGDs) and workshop detailed within this protocol 
will aim to expand a policy dialogue on socioeconomic support 
for TB-affected households among key stakeholders in Nepal, 
from people with TB to community leaders to TB healthcare 
professionals. Policy dialogues represent knowledge transla-
tion to support the integration of research evidence with tacit 
knowledge of local health policy-makers to: inform future 
policy decisions in often complex and dynamic contexts; and 
foster proactive collaboration26,27. These elements will be critical 
for successful implementation of any future interventions28.
In summary, this mixed-methods research will complement 
and extend the existing knowledge base on social determi-
nants and consequences of TB. More specifically, the culmina-
tion of the research will be the creation of a shortlist of feasible 
and locally-appropriate socioeconomic interventions for 
TB-affected households for future randomized controlled 
trial evaluation in Nepal.
Protocol
Ethical statement
Ethical approval was granted from the University of Liverpool, 
UK, research ethics committee in April 2018 (approval 
number 2436) and then the National Health Research Coun-
cil of Nepal (NHRC) research ethics committee in May 2018 
(approval number 320/2018).
Participant information leaflets will be provided and written 
informed consents will be obtained from all study participants 
for Project 1 Interviews (separate consent forms and infor-
mation leaflets for patients and healthy controls), Project 2 
Surveys, FGDs, and the workshop. These documents are 
available in the Extended Data section attachments29.
All medical records obtained from the Nepal NTP will be kept 
confidential. Practically, through liaison with NTP Project 
Staff (as already organised for IMPACT-TB), the PM, PI, and 
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RA will photocopy patient records from the Nepal NTP TB 
register obscuring the patient’s identifiable details. Photocopies 
will be marked with that patient’s unique study number identi-
fier. No individual patients will be identifiable from publications 
resulting from this study.
Study design
This mixed-methods study was funded by a Wellcome Trust 
Seed Award in Science (awards provided to early-career 
researchers to develop a novel idea that will go on to form part 
of a larger grant application) and will be divided into two com-
plementary projects. Project 1 consists of a cohort study 
characterising the socioeconomic impact of TB on TB-affected 
households and a nested case-control study examining the 
social determinants of TB. Project 2 consists of a mixed quan-
titative-qualitative cross-sectional study using surveys, FGDs 
and a workshop to identify the barriers and facilitators to 
accessing and engaging with TB diagnosis and care in Nepal 
and suggesting potential interventions to mitigate the socio-
economic impact and improve access and engagement. The 
study will take place within the infrastructure of the larger 
EU-Horizon 2020 funded “IMPACT-TB” project, which is a 
study evaluating proven TB active case-finding (ACF) 
interventions in Nepal and Vietnam (grant 733174, http://www.
impacttbproject.org/).
Primary aims
The primary aim of Project 1 is to evaluate the socioeconomic 
impact on TB-affected households of accessing and engaging 
with TB diagnosis and care in Nepal and compare that impact 
in people with TB identified through standard passive case find-
ing (PCF) versus ACF. The primary aim of Project 2 is to 
collaborate with key stakeholders in Nepal to create a shortlist 
of potentially feasible and locally-appropriate socioeconomic 
interventions to mitigate this impact.
Secondary aims
The secondary aim of Project 1 is to compare the social deter-
minants of TB (including socioeconomic position, housing 
situation, knowledge about TB, comorbidities, quality of life, 
food security, and social capital) in people with TB versus 
people without TB from the same districts. The secondary aim 
of Project 2 is to collate the opinions of key stakeholders from 
diverse sectors about barriers and facilitators to accessing and 
engaging with TB care in Nepal.
An additional aim across the study is to generate a policy 
dialogue and form a collaborative research network to sup-
port development and implementation of a future randomised 
control trial of socioeconomic support for TB-affected 
households in Nepal.
Study setting
The study will take place within the infrastructure of the larger 
IMPACT-TB study, which works with a well-established 
international non-governmental organisation, Birat Nepal 
Medical Trust (BNMT), to implement ACF activities includ-
ing sputum-microscopy camps and roll-out of GeneXpert 
OMNI in four intervention and two control districts (with PCF 
only). The four districts are located in the central develop-
ment region of Nepal and were selected for the IMPACT-TB 
project based on comparable populations and TB case detection 
rates (Figure 2).
The primary outcome of IMPACT-TB is the effect of ACF on 
early TB case detection and the study does not involve sup-
port packages for TB-affected households during treatment. 
This presents a unique opportunity for the complementary 
research described in this protocol to add value to IMPACT-TB, 
explore the socioeconomic impact of accessing TB care, 
and shortlist locally-driven strategies to reduce this impact.
Study population
Participant identification, recruitment and follow-up. During 
Project 1, approximately 200 people with TB (cases) con-
secutively recruited to Work Package 3 (WP3) of IMPACT-TB 
(Health Economic Analysis) in the four study sites will be fur-
ther recruited to this study. 100 of these cases will have been 
diagnosed through ACF and 100 diagnosed through PCF. 
Whilst attending the NTP TB clinic, these people with TB will 
be invited to participate in this mixed-methods research with 
a separate written, informed consent (see Project 1 Interview 
Patient Consent Form, Extended data)29. During months three 
and six of their TB treatment, household visits will be conducted 
by BNMT project staff including community mobilisers.
Concurrently, 100 people without TB from the study sites 
(controls) will be invited to participate with written, informed 
consent (see Project 1 Interview Healthy Control Consent 
Form, Extended data)29. Due to constraints in study budget, dura-
tion, and field logistics, it will not be possible to age and sex 
match cases and controls nor to randomly select controls using 
geospatial or other household randomisation techniques. There-
fore, a convenience sampling strategy was used. In order to be 
as widely representative of and generalisable to the background 
population as possible, following project team and commu-
nity mobiliser discussions in the study sites, we opted to recruit 
control participants from diverse locations within the districts, 
which were attended by a broad demographic cross-section of 
the local population in terms of age, gender, and socioeconomic 
position. These diverse study site locations include: tea houses, 
primary healthcare centres, antenatal and immunization clin-
ics, door-to-door visits following sputum camps (e.g. people who 
tested negative for TB), and public gathering places. Interview-
ers will visit the control recruitment locations at similar times 
of the morning and aim to consecutively recruit all individuals 
in attendance at that location. Similar numbers of participants 
from each recruitment location will be recruited until the sam-
ple size of 100 people without TB is reached. We acknowledge 
that convenience sampling may be associated with a higher like-
lihood of a non-generalisable control cohort than other tech-
niques. To try to address this, the survey used to collect data 
from the controls has incorporated multiple questions concerning 
sociodemographic variables, including education level, occupa-
tion, amenities, and assets, from the most recent version of the 
Nepal Household Survey, which is publicly available. Descriptive 
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analysis will evaluate whether the controls recruited are 
representative of the wider population in those districts through 
comparison of their sociodemographic data with respondents 
to the national survey in the same districts. Any differences between 
the control population and background population will then 
be highlighted transparently in corresponding research outputs 
and publications.
Project 1 inclusion criteria for Cases included: being a per-
son with TB notified to the NTP and recruited to WP3 of the 
IMPACT-TB study; being aged 18 years or above; and giv-
ing verbal and written informed consent to participate. Project 
1 exclusion criteria for Cases included: being under 18 
years of age; being a person with TB not notified to the NTP 
and/or not recruited to WP3 of the IMPACT-TB study; being 
a person with TB notified to the NTP but with a recorded 
domiciliary address outside of the study site districts; and 
being unable or unwilling to give written and/or verbal informed 
consent to participate.
Project 1 inclusion criteria for Controls included: being 18 
years or above with primary residence in the study site com-
munities; not currently known to be a person with TB or have a 
member of the household currently known to be a person with 
TB (e.g. not diagnosed or notified or receiving TB treatment); 
and giving verbal and written informed consent to participate. 
Project 1 exclusion criteria for Controls included: being under 
18 years of age; not having primary residence in the study 
site communities; known to be a person with TB or have a 
household member with TB currently (e.g. diagnosed and/or 
notified and/or receiving TB treatment); and being unable 
or unwilling to give verbal and written informed consent to 
participate. 
To generate the population for Project 2, a literature review 
and desk-based scoping review will identify a list of key 
in-country stakeholders from Nepal from diverse groups 
including: civil-society representatives; community leaders; 
and TB healthcare professionals including NTP managers and 
multi-disciplinary staff. Approximately 50 stakeholders will be 
selected through purposive sampling and invited to participate 
in: a pre-FGD survey, FGD, and a one-day workshop. A sub-
set of purposively sampled TB patients recruited to Project 1 
(including those with multi-drug resistant TB) will be among 
the stakeholders invited to participate.
Project 2 inclusion criteria include: being aged 18 years or 
above; belonging to a stakeholder group as defined above and/
or identified during scoping exercise; and being able and will-
ing to provide verbal and written, informed consent. Exclu-
sion criteria for Project 2 are not meeting the inclusion criteria 
and/or being a person with TB who has not yet taken two 
weeks of TB treatment or is otherwise considered to still be 
infectious (e.g. MDR-TB with positive sputum smear or culture).
Figure 2. Map, population, and TB case notification rate of the four study site districts. Data for population and TB cases notification rate 
shown is taken from the Nepal TB Centre 2018 report. The four study site districts are labelled and highlighted in blue and green.
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Sample size and statistical power. The sample size for Project 
1 is approximately 200 Cases recruited to WP3 of the IMPACT-
TB project and 100 Controls from the four study site dis-
tricts. This sample size is opportunistic and pragmatic: related 
research suggests that data from 100 people with TB gives a 
representative spread of costs for a given context30,31.
For Project 2, each FGD will consist of approximately eight 
stakeholders. The estimated number of FGDs at which infor-
mation power (or saturation level) will be reached is six12. 
Thus, the sample size for Project 2 is approximately 40 stake-
holder participants. We will invite 55 stakeholders as a con-
tingency because we anticipate an attrition rate of 20–30% 
during the course of Project 2.
Given that this Seed Award research will be exploratory, 
preparatory (e.g. for the future trial), and does not include an 
intervention, no calculations of statistical power are required.
Study interventions
The study will not include any interventions or require any 
patient samples (e.g. blood / sputum / tissue).
Study activities
Broadly, the activities involved in the research will include 
interviews with Cases and Controls during household 
visits, and a pre-FGD survey, FGD, and workshop with key 
stakeholders.
During Project 1, the project team will support BNMT district 
coordinators, community mobilisers, and community volun-
teers to do household visits to approximately 200 Cases with TB 
(100 diagnosed through ACF and 100 through PCF) recruited 
to WP3 of the IMPACT-TB project. People with TB will 
receive two household visits, the first during month three of TB 
treatment and the second visit during month six of TB treat-
ment (to correspond with treatment completion). For con-
trols, a single household visit and interview will be done. 
The interviews will be structured (see Project 1 Interview, 
Extended data)29 and gather data on: i) socioeconomic posi-
tion, evaluated by a multi-dimensional poverty score6,9,13,15 
assessing dwelling characteristics, assets, and access to ameni-
ties; ii) household structure, including distribution of age, sex, 
and employment of household members; iii) food expendi-
ture and security; iv) costs of engaging with TB care including 
direct costs (e.g. medicines, clinic visits, food, and travel) and 
indirect costs (e.g. lost income), which will be evaluated using 
an adapted version of WHO’s TB Patient Costs Survey inte-
grated into the interview22,23;. v) coping strategies including dis-
saving (e.g. selling assets), schooldays lost, and temporary 
income-generating activities; vi) TB-related knowledge includ-
ing understanding of transmission, prevention, and treatment 
of TB; vii) psychosocial situation evaluated through questions 
relating to social capital, quality of life, and stigma (Controls 
without TB will not be asked any questions about the impact that 
having TB disease has on their psychosocial situation); and viii) 
access and uptake of existing social protection schemes (whether 
TB-specific or TB-inclusive) and support for TB-affected 
households, evaluated through use of both closed ranking and 
open free-text questions to establish what socioeconomic and 
other support people with TB and their households receive or 
would like to receive.
Prior to implementation of household visits, the question-
naire will be translated from English into Nepali and then back-
translated into English. It will be assessed by members of the 
study team and BNMT implementation staff before being 
piloted in approximately 10 patients. The questionnaire may 
subsequently be refined and questions deleted or added, 
depending on the pilot outcomes.
In addition to the above, Cases’ TB treatment outcomes will 
be collated from NTP and IMPACT-TB data and their asso-
ciation with interview responses analysed. This will provide 
an exploratory analysis of the association of socioeconomic 
position, socioeconomic impact of having TB, and TB treat-
ment outcomes. A comparison of the socioeconomic position 
of households of Cases and Controls will also be made.
Project 2 will use and develop mixed methods research 
techniques10–15 to conduct a pre-FGD survey, FGDs, and work-
shop with approximately 40 key stakeholders in Nepal to identify 
the socioeconomic impact, barriers and facilitators to accessing 
and engaging with TB diagnosis and care. To inform the design 
of the FGDs and workshop, we created a conceptual framework 
for the barriers and facilitators to TB diagnosis and care, which 
was adapted from a World Health Organisation framework for 
medication adherence (Figure 3)32.
A short individual pre-FGD survey (see Project 2 Survey, 
Extended data)29 will be provided to participants prior to the 
initiation of an FGD. The survey will detail: participants’ 
demographics; the stakeholder group to which the partici-
pant belongs; and their opinions on community, patient, health 
system, existing social protection schemes, and wider obstacles 
to achieving successful TB treatment  outcomes.
The FGDs will be semi-structured and incorporate open-ended 
questions concerning barriers and facilitators to accessing 
and engaging with TB care in Nepal, and existing platforms 
and potential opportunities to mitigate these barriers including 
social protection schemes (see Project 2 Focus Groups, Extended 
data)29. The FGDs will be conducted with separate groups of 
approximately eight key stakeholders. Stakeholders will be 
invited to participate according to their background (e.g. peo-
ple with TB will be asked to participate in one FGD, and TB 
healthcare professionals will be asked to participate in another 
separate FGD). Towards the end of each FGD, participants will be 
asked to privately rank the top three most important barriers or 
facilitators to accessing TB diagnosis and care identified by the 
group during the FGD, and these responses will be collated for 
each FGD and across FGDs. The FGDs will be moderated by 
members of the project team trained in qualitative methods 
including conducting FGDs. The discussions will be audio recorded 
in Nepali language, translated into English, and back-translated 
by a translator who is not part of the project team. Each FGD 
group will be asked to elect a representative to feed their 
group’s outputs back at the subsequent workshop.
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The final activity in Project 2 will be a one-day workshop bring-
ing together the 40 key stakeholders (see Project 2 Workshop, 
Extended data)29. The morning section of the workshop will 
consist of interactive presentations from the project team and 
stakeholder group representatives (including leaders of national 
social protection schemes in Nepal), and discussions exploring 
and validating the barriers and opportunities identified during 
the pre-FGD survey and interviews during FGDs. The after-
noon section of the workshop will consist of multi-sectoral 
working groups (a10 diverse stakeholders) developing a short-
list of potential socioeconomic interventions for TB-affected 
households in Nepal. The shortlist is not intended to consist of 
defined, unalterable packages, which are immediately ready 
for trial implementation. Rather, the potential interventions 
selected are intended to consist of what stakeholders perceive 
to be key elements or ingredients of psychosocial and economic 
support for TB-affected households, which are feasible and 
locally-appropriate to the Nepalese context. The interventions 
will be presented to the group including strengths, weaknesses, 
and potential sources of funding for implementation.
The activities involved in this research form part of a proc-
ess to develop and evaluate a complex, socioeconomic sup-
port intervention. In line with the Medical Research Council’s 
guidance on process evaluation of complex interventions, we 
developed a logic model to illustrate the developmental stages of 
the intervention (Figure 4)33.
This Wellcome research will aim to achieve the short-term 
outcomes described in the logic model. If follow-on funding is 
successfully obtained, the process to develop and implement the 
intervention and achieve the long-term outcomes will continue 
beyond this Wellcome research. This will include adaptation, 
piloting, and then large-scale randomised trial evaluation of 
the refined intervention.
Outcomes to be measured
This exploratory Wellcome Trust funded Seed Award in 
Science research in four districts of Nepal will: 
i.  characterise social determinants of TB by comparing
poverty level, education level, food security, and other
socioeconomic factors of people with TB (Cases) versus
people without TB (Controls);
ii.  provide new insight into the barriers, facilitators,
and socioeconomic impact of being ill with TB and
accessing TB diagnosis and care, and compare this in
Cases diagnosed by ACF versus PCF; and
Figure 3. Conceptual framework: the barriers and facilitators to TB diagnosis and care. The central circle, which contains dimensions 
of medication adherence adapted from the World Health Organization32, is surrounded by the five main categories of relevant potential 
interventions. The factors that may promote access to and engagement with TB services (facilitators) are shown in green boxes and factors 
that may threaten access and engagement (barriers) are shown in white boxes. Therapeutic alliance refers to strong provider-patient 
relationships. Although Project 2 would gather data on all five dimensions, the psychosocial and social protection dimensions were perceived 
by the project team to be most pertinent to development of the socioeconomic intervention and were selected for further focus and discussion 
during Project 2’s workshop.
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Figure 4. Logic model for research in Nepal to develop a locally-appropriate socioeconomic support intervention for TB-affected 
households. Abbreviations: CSOs = Civil Society Organisations; NGOs = Non-governmental organisations; NTP = National Tuberculosis 
Programme; WHO = World Health Organisation; SPARKS = Social Protection Action Research and Knowledge Sharing network (www.sparks.
ki.se)  
iii.    generate a community-led shortlist of the most feasi-
ble, equitable, and locally-appropriate socioeconomic 
interventions for TB-affected households to mitigate 
the socioeconomic impact of TB.
Data collection and management
During the implementation of Project 1, information will be 
collected by BNMT district coordinators, community vol-
unteers, and community mobilisers with support from the 
project team during visits to recruited patient households. 
This information includes but is not limited to socioeconomic, 
health, psychosocial, and behavioural data. This data will be 
collected on paper due to digital collection (e.g. on tablets or 
mobile phones) having issues with security and feasibility. 
The data of consenting TB patients will subsequently be 
linked with data from NTP’s TB patient register as part of its 
routine surveillance data collection at the intervention and 
control areas, with pre-existing permission from the NTP.
During Project 2, key stakeholders identified by the scoping 
exercise will complete a short pre-FGD survey in person, 
participate in an FGD, and participate in a one-day workshop.
All paper-based copies, including medical records, informed 
consent forms and participant information leaflets, will con-
tain only a unique study identifier for each participant. These 
documents will be stored in a locked room in the BNMT office. 
Data will be checked for consistency and completeness by 
the project manager and double-checked by the PI prior to 
entering into an encrypted access database. The database 
will be managed by the data management team at KNCV TB 
Foundation in The Netherlands in line with data collected 
during the IMPACT-TB project. The data will be protected by 
KNCV on a password-secured server with availability limited to 
only key members of the study team when required for analysis.
Data analysis and statistical plan
The quantitative data collected during the household visits of 
Project 1 will be analysed using simple descriptive statistics. 
Continuous costs data will be summarised by their arithme-
tic means and their 95% confidence intervals whether the data 
is Gaussian or non-Gaussian, because this approach is con-
sidered to be robust for health economics data analysis6,34–36. 
Furthermore, because of the skewed nature of some expendi-
ture data, median values may be zero or close to zero limit-
ing the descriptive usefulness of presenting median values. As 
described in the PI’s previous research6, any direct expenses, 
lost income, or annual income recorded as “zero” or miss-
ing will be replaced with the mean cost of each costs category, 
i.e. mean direct costs or lost income. The local currency, 
Nepalese rupee, will be converted into United States Dollars 
(conversion rate and date estimated through Oanda at time 
of data collection). Categorical data will be summarised as 
proportions with 95% confidence intervals.
With regards to analysis of household income and expenditure, 
the WHO TB Patients Costs Survey methods will be followed. 
In order to evaluate the optimal analytical strategy for costs 
data in Nepal, the analysis will compare and contrast the differ-
ent approaches used in the WHO Survey to estimate household 
income (self-reported household consumption; self-reported 
household expenditure; self-reported household income; and 
estimated income based on household asset ownership and 
dwelling characteristics) and lost income (output approach 
of reported income pre- and during TB versus human capi-
tal approach of multiplying hours of work lost by hourly rate or 
daily in rate in cases of hospitalised patients).
Social determinants of TB including sociodemographic charac-
teristics, socioeconomic position, stigma and social capital lev-
els, and TB-related knowledge will be compared between ACF 
patients, PCF patients, and controls using Chi-squared test, 
Pearson’s test, one-way ANOVA, and multiple logistic regres-
sion models where appropriate. No comparison will be made 
between patients and controls concerning healthcare expenditure as 
this data was not collected from controls. Statistical analysis 
will be performed using the statistical software package STATA 
v13.1 (Statacorp, TX, USA).
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The Framework method of thematic analysis will be used to man-
age and analyse data from Project 2 via the NVivo qualitative 
software package (Version 12) as per published social policy and 
tuberculosis research21–24. Specifically, two researchers (KD and 
TW) will familiarize themselves with the data through successive 
reading of transcripts; use both open and closed first 
order data coding to label data within NVivo; group codes 
together into a second order codebook of themes and sub-themes. 
Themes and subthemes will then be further stratified by third 
order coding to the level at which they predominantly occurred 
(e.g. individual or household level, health systems level, 
community level, or governmental level). The primary approach 
to codes, themes, and sub-themes will be deductive (top down), 
being informed by our conceptual framework and prelimi-
nary analysis of data from Project 1 relating to the social deter-
minants and consequences identified. As coding continues, a 
secondary approach will integrate inductive (bottom up) cod-
ing in order to be iterative, responsive, and flexible as further 
data becomes available and is collated following each successive 
FGD.
Plans for dissemination of study findings
The intended research outputs of this work are to: i) present 
the interim and final findings at the International Union 
Against TB and Lung Disease in October 2019 and Octo-
ber 2020, respectively; ii) publish, by June 2020, at least two 
papers in high-impact, peer-reviewed journals concerning the 
socioeconomic impact of accessing TB care in Nepal and the 
collaborative development of a shortlist of locally-appropriate 
socioeconomic interventions in Nepal; iii) feedback find-
ings to the IMPACT-TB team, key stakeholders (including 
NTP and TB civil-society), the SPARKS (Social Protection 
Action Research and Knowledge Sharing) network, and WHO; 
iv) consolidate a close collaboration, good working rela-
tionship, and strong research infrastructure between BNMT 
and the NTP; and iv) to develop the protocol for a robust, 
large-scale randomised controlled trial to evaluate socioeco-
nomic support for TB-affected households using the evidence 
generated by this mixed-methods study.
Study status
Data collection for Project 1 during household visits began 
in May 2018 and is nearly complete at the time of writing with 
only TB treatment outcome data still being collected. Data 
collection for Project 2 during pre-FGD surveys and FGDs 
began in August 2018 and was completed in July 2019. The 
national workshop with key stakeholders was conducted on 
11 and 12 September 2019 in Kathmandu, Nepal.
Data analysis, write-up, and dissemination of findings will begin 
in February 2020.
Discussion
The overarching pledge of the Sustainable Development Goals 
(SDGs) is to “leave no one behind”. In 2018, over 3 million 
people with tuberculosis (TB) were not diagnosed, not noti-
fied, or their quality of care was unknown. In the same year, 
1.5 million people with TB died and nearly a fifth of 
people diagnosed with TB did not have a successful treatment 
outcome16. While millions of people with TB continue to be 
left behind, the SDG pledge is far from being realised.
Despite renewed interest in addressing social determinants 
of tuberculosis, there remain stark global inequalities in dis-
ease burden and access to TB care8. At a population level, 
LICs bear the highest TB prevalence16. At an individual level, 
people with TB are often vulnerable, impoverished, and their 
households suffer disproportionate financial shock due to their 
illness6,13. To eliminate such gross disparity, SDG slogans must be 
turned into actions.
WHO’s 2015 End TB Strategy acknowledges the need to reduce 
inequalities in TB prevention and care. A key component of 
Pillar 2 (Bold policies and supportive systems) of the strategy is 
social protection and poverty alleviation to reduce catastrophic 
costs of TB-affected households and improve TB outcomes2. 
However, there is minimal evidence to guide this policy change.
This mixed-methods will generate evidence concerning the 
socioeconomic position of TB-affected households, the impact 
that having TB disease has on that position and explore the 
coping strategies that households use to mitigate the impact 
of the disease. Moreover, this research will: use methods to 
measure costs of TB-affected households to which mem-
bers of the study team contributed as part of the WHO Task 
Force on Catastrophic Costs of Tuberculosis; and provide the 
first known comparison of the socioeconomic impact of TB 
on people with TB diagnosed through PCF versus ACF. The 
case-control element of Project 1 will allow comparison of the 
sociodemographic characteristics, socioeconomic position, stigma 
and social capital levels, and TB-related knowledge between 
people with TB (Cases) and people without TB (Controls).
The further significance of the study lies in its development 
of a shortlist of a locally-generated intervention to provide 
socioeconomic support to TB-affected households. Through 
collaboration with diverse stakeholders in Nepal from patients 
to NTP managers to civil-society representatives, it is hoped 
that the shortlist created will feature interventions that are 
both locally-appropriate and feasible. Furthermore, this 
tight collaboration should aid design and implementation of 
a larger, randomised-controlled trial, and also future transla-
tion of research findings into national policy in Nepal. Beyond 
the national impact, these findings and those of the future 
trial will also offer evidence for scale-up of socioeconomic 
support in other resource-limited countries with a high TB bur-
den. Complementary to pills and tests, this socioeconomic 
support will be an essential part of eliminating TB by 2050.
Conclusions
This mixed-methods study will fill this existing evidence gap 
by examining the costs of accessing TB care at a household 
level through longitudinal application of an adapted WHO TB 
Patient Costs Survey throughout TB treatment. This data will 
be enriched by collecting complementary data on household 
socioeconomic position, coping strategies, food insecurity, 
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